HMG-I/Y, a New c-Myc Target Gene and Potential Oncogene

REFERENCES

• Abate, C., Luk, D., Gentz, R., Rauscher, F. J.III, and Curran, T.. 1990. Expression and purification of the leucine zipper and DNA-binding domains of Fos and Jun: both Fos and Jun contact DNA directly. Proc. Natl. Acad. Sci. USA 87:1032–1036
   PubMed Web of Science ®Google Scholar
• Amin, C. A., Wagner, J., and Hay, N.. 1993. Sequence-specific transcriptional activation by Myc and repression by Max. Mol. Cell. Biol. 13:383–390
   PubMed Web of Science ®Google Scholar
• Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K.. 1990. Current protocols in molecular biology. John Wiley & Sons, New York, N.Y
   Google Scholar
• Auvinen, M., Laine, A., Paasinen-Sohns, A., Kangas, A., Kangas, L., Saksela, O., Andersson, L. C., and Holtta, E.. 1997. Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice. Cancer Res. 57:3016–3025
   PubMed Web of Science ®Google Scholar
• Auvinen, M., Paasinen, A., Andersson, L. C., and Holtta, E.. 1992. Ornithine decarboxylase activity is critical for cell transformation. Nature 360:355–358
   PubMed Web of Science ®Google Scholar
• Barrett, J., Birrer, M. J., Kato, G. J., Dosaka-Akita, H., and Dang, C. V.. 1992. Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells. Mol. Cell. Biol. 12:3130–3137
   PubMed Web of Science ®Google Scholar
• Bello-Fernandez, C., Packham, G., and Cleveland, J. L.. 1993. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl. Acad. Sci. USA 90:7804–7808
   PubMed Web of Science ®Google Scholar
• Ben-Porath, I., Yanuka, O., and Benvisty, N.. 1999. The Tmp gene, encoding a membrane protein, is a c-Myc target with a tumorigenic activity. Mol. Cell. Biol. 19:3529–3539
   PubMedGoogle Scholar
• Benvenisty, N., Leder, A., Kuo, A., and Leder, P.. 1992. An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence. Genes Dev. 6:2513–2523
   PubMedGoogle Scholar
• Berlingieri, M. T., Manfioletti, G., Santoro, M., Bandiera, A., Visconti, R., Giancotti, V., and Fusco, A.. 1995. Inhibition of HMG-C protein synthesis suppresses retrovirally induced neoplastic transformation. Mol. Cell. Biol. 15:1545–1553
   PubMed Web of Science ®Google Scholar
• Blackwell, T. K., Kretzner, L., Blackwood, E. M., Eisenman, R. N., and Weintraub, H.. 1990. Sequence-specific DNA binding by the c-Myc protein. Science 250:1149–1151
   PubMed Web of Science ®Google Scholar
• Blackwood, E. M., and Eisenman, R. N.. 1991. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Max. Science 251:1211–1217
   PubMed Web of Science ®Google Scholar
• Boyd, K. E., and Farnham, P. J.. 1997. Myc versus USF: discrimination at the cad gene is determined by core promoter elements. Mol. Cell. Biol. 17:2529–2537
   PubMed Web of Science ®Google Scholar
• Bussemakers, M. J. G., van de Ven, W. J. M., Debruyne, F. M. J., and Schalken, J.. 1991. Identification of high mobility group I(Y) as potential progression marker for prostate cancer by differential hybridization analysis. Cancer Res. 51:606–611
   PubMed Web of Science ®Google Scholar
• Chiapetta, G., Bandiera, A., Berlingiera, M. T., Visconti, R., Manfioletti, G., Battista, S., Martinez-Tello, F. J., Santoro, M., Giancotti, V., and Fusco, A.. 1995. The expression of the high mobility group HMGI(Y) protein correlates with the malignant phenotype of human thyroid neoplasias. Oncogene 10:1307–1314
   PubMed Web of Science ®Google Scholar
• Cochran, B. H., Reffel, A. C., and Stiles, C. D.. 1983. Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell 33:939–947
   PubMed Web of Science ®Google Scholar
• Cole, M. D.. 1991. Myc meets its Max. Cell 65:715–716
   PubMedGoogle Scholar
• Cole, M. D., and McMahon, S. B.. 1999. The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene 18:2916–2924
   PubMed Web of Science ®Google Scholar
• Daksis, J. I., Lu, R. Y., Facchini, L. M., Marhin, W. W., and Penn, L. J. Z.. 1994. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene 9:3635–3645
   PubMed Web of Science ®Google Scholar
• Dang, C. V.. 1999. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19:1–11
   PubMed Web of Science ®Google Scholar
• Dang, C. V., Barrett, J., Villa-Garcia, M., Resar, L. M. S., Kato, G. J., and Fearon, E. R.. 1990. Intracellular leucine zipper interactions suggest c-Myc heterodimerization. Mol. Cell. Biol. 11:954–962
   Google Scholar
• Dang, C. V., and Lee, L. A.. 1995. c- myc function in neoplasia. R. G. Landes, Austin, Tex
   Google Scholar
• DePino, R. A., Schreiber-Agus, N., and Alt, F. W.. 1991. Myc family oncogenes in the development of normal and neoplastic cells. Adv. Cancer Res. 57:1–46
   PubMedGoogle Scholar
• Desbarats, L., Gaubatz, S., and Eilers, M.. 1996. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc. Genes Dev. 10:447–460
   PubMed Web of Science ®Google Scholar
• Du, W., Thanos, D., and Maniatis, T.. 1993. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell 74:887–898
   PubMed Web of Science ®Google Scholar
• Eilers, M., Picard, D., Yamamoto, K. R., and Bishop, J. M.. 1989. Chimeras between the MYC oncoprotein and steroid receptors cause hormone-dependent transformation in cells. Nature 340:66–68
   PubMedGoogle Scholar
• Eilers, M. S., Schirm, S., and Bishop, J. M.. 1991. The MYC protein activates transcription of the α- prothymosin gene. EMBO J. 10:133–141
   PubMed Web of Science ®Google Scholar
• Evan, G. I., and Littlewood, T. D.. 1993. The role of c- myc in cell growth. Curr. Opin. Gene Dev. 3:44–49
   PubMedGoogle Scholar
• Facchini, L. M., and Penn, L. Z.. 1998. The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J. 12:633–651
   PubMed Web of Science ®Google Scholar
• Falvo, J. V., Thanos, D., and Maniatis, T.. 1995. Reversal of intrinsic DNA bends in the IFNβ gene enhancer by transcription factors and the architectural protein HMG I(Y). Cell 83:1101–1111
   PubMed Web of Science ®Google Scholar
• Friedmann, M., Holth, L. T., Zoghbi, H. Y., and Reeves, R.. 1993. Organization, inducible expression and chromosomal localization of the human HMG-I(Y) nonhistone protein gene. Nucleic Acids Res. 21:4259–4267
   PubMed Web of Science ®Google Scholar
• Galaktionov, K., Chen, X., and Beach, D.. 1996. cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382:511–517
   PubMed Web of Science ®Google Scholar
• Galaktionov, K., Lee, A. K., Eckstein, J., Draetta, G., Meckler, J., Loda, M., and Beach, D.. 1995. CDC25 phosphatases as potential human oncogenes. Science 269:1575–1577
   PubMed Web of Science ®Google Scholar
• Gaubatz, S., Imhof, A., Dosch, R., Weiner, O., Mitchell, P., Buettner, R., and Eilers, M.. 1995. Transcriptional activation of Myc is under negative control by transcription factor AP-2. EMBO J. 14:1508–1519
   PubMed Web of Science ®Google Scholar
• Gaubatz, S., Meichle, A., and Eilers, M.. 1994. An E-box element localized in the first intron mediates regulation of the prothymosin α gene by c-myc. Mol. Cell. Biol. 14:3853–3862
   PubMedGoogle Scholar
• Gerdes, J., Schwab, U., Lemke, H., and Stein, H.. 1983. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer. 13:13–20
   Google Scholar
• Gerdes, J., Carsten Schlueter, L. L., Duchrow, M., Wohlenberg, C., Gerlach, C., Stahmer, I., Kloth, S., Brandt, E., and Flad, H.-D.. 1991. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am. J. Pathol. 138:867–873
   PubMed Web of Science ®Google Scholar
• Giancotti, V., Bandiera, A., Buratti, E., Fusco, A., Marzari, R., Coles, B., and Goodwin, G. H.. 1991. Comparison of multiple forms of the high mobility group I proteins in rodent and human cells. Identification of the human high mobility group I-C protein. Eur. J. Biochem. 198:211–216
   PubMedGoogle Scholar
• Giancotti, V., Bandiera, A., Ciani, L., Santro, D., Crane-Robinson, C., Goodwin, G. H., Boiocchi, M., Dolcetti, R., and Casetta, B.. 1993. High-mobility-group (HMG) proteins and histone H1 subtypes expression in normal and tumor tissues of mouse. Eur. J. Biochem. 213:825–832
   PubMedGoogle Scholar
• Giancotti, V., Berlingieri, M. T., DiFiore, P. P., Fusco, A., Veccio, G., and Crane-Robinson, C.. 1985. Changes in nuclear proteins following transformation of rat thyroid epithelial cells by a murine sarcoma retrovirus. Cancer Res. 45:6051–6057
   PubMed Web of Science ®Google Scholar
• Giancotti, V., Buratti, E., Perissin, L., Zorzet, S., Balman, A., Portella, G., Fusco, A., and Goodwin, G. H.. 1989. Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures. Exp. Cell Res. 184:538–545
   PubMedGoogle Scholar
• Giancotti, V., Pani, B., D'Andrea, P., Berlingieri, M. T., DiFiore, P. P., Fusco, A., Veccio, G., Philip, R., Crane-Robinson, C., Nicolas, R. H., Wright, C. A., and Goodwin, G. H.. 1987. Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with v- ras and v- mos oncogenes and by co-transfection with c- myc and polyoma middle T genes. EMBO J. 6:1981–1987
   PubMed Web of Science ®Google Scholar
• Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., and Giaccia, A.. 1996. Hypoxia-mediated selection of cells with diminished apoptotic potential on solid tumors. Nature 379:88–91
   PubMed Web of Science ®Google Scholar
• Grandori, C., Mac, J., Siebelt, F., Ayer, D. E., and Eisenman, R. N.. 1996. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO J. 15:4344–4357
   PubMed Web of Science ®Google Scholar
• Grandori, C., and Eisenman, R. N.. 1997. Myc target genes. Trends Biochem. Sci. 22:177–181
   PubMed Web of Science ®Google Scholar
• Gu, W., Cechova, K., Tassi, V., and Dalla-Favara, R.. 1993. Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. Proc. Natl. Acad. Sci. USA 90:2935–2939
   PubMedGoogle Scholar
• Hoang, A. T., Cohen, K. J., Barrett, J. F., Bergstrom, D. A., and Dang, C. V.. 1994. Participation of cyclin A in Myc-induced apoptosis. Proc. Natl. Acad. Sci. USA 91:6875–6877
   PubMedGoogle Scholar
• Holozoneti, T. D., and Kandil, A. N.. 1991. Determination of the c-Myc DNA-binding site. Proc. Natl. Acad. Sci. USA 88:6162–6166
   PubMedGoogle Scholar
• Holth, L. T., Thorlacius, A. E., and Reeves, R.. 1997. Effects of epidermal growth factor and estrogen on the regulation of the HMG-I/Y gene in human mammary epithelial cell lines. DNA Cell Biol. 16:1299–1309
   PubMedGoogle Scholar
• Johnson, K. R., Cook, S. A., and Davisson, M. T.. 1992. Chromosomal localization of the murine gene and 2 related sequences encoding high-mobility group I and Y proteins. Genomics 12:503–509
   PubMedGoogle Scholar
• Johnson, K. R., Lehn, D. A., Elton, T. S., Barr, P. J., and Reeves, R.. 1988. The chromosomal high mobility group protein HMG-I(Y): complete murine cDNA sequence, genomic structure, and tissue expression. J. Biol. Chem. 18:18338–18342
   Google Scholar
• Jones, D. H., and Winistorfer, S. C.. 1992. Recombinant circle PCR for site-specific mutagenesis without PCR product purification. BioTechniques 12:528–534
   PubMedGoogle Scholar
• Jones, R. M., Branda, J., Johnston, K. A., Polymenis, M., Gadd, M., Rustgi, A., Callanan, L., and Schmidt, E. V.. 1996. An essential E box in the promoter of the gene encoding the mRNA cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-Myc. Mol. Cell. Biol. 16:4754–4764
   PubMed Web of Science ®Google Scholar
• Kato, G., Barrett, J., Villa-Garcia, M., and Dang, C. V.. 1990. An amino-terminal c-Myc domain required for neoplastic transformation. Mol. Cell. Biol. 10:5914–5920
   PubMed Web of Science ®Google Scholar
• Kato, G. J., Lee, W. M. F., Chen, L., and Dang, C. V.. 1992. Max: functional domains and interaction with c-Myc. Genes Dev. 6:81–92
   PubMed Web of Science ®Google Scholar
• Keath, E. J., Caimi, P. G., and Cole, M. D.. 1984. Fibroblast lines expressing activated c- myc oncogenes are tumorigenic in nude mice and syngeneic animals. Cell 39:339–348
   PubMed Web of Science ®Google Scholar
• Kerkhoff, E., Bister, K., and Klempnauer, K. H.. 1991. Sequence-specific DNA binding by Myc proteins. Proc. Natl. Acad. Sci. USA 88:4323–4327
   PubMed Web of Science ®Google Scholar
• Laborda, J.. 1991. 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res. 19: 3998
   PubMed Web of Science ®Google Scholar
• Lanahan, A., Williams, J. B., Sanders, L. K., and Nathans, D.. 1992. Growth factor-induced delayed early-response genes. Mol. Cell. Biol. 12:3919–3929
   PubMed Web of Science ®Google Scholar
• Lewis, B. C., Shim, H., Li, Q., Wu, C. S., Lee, L. A., Maity, A., and Dang, C. V.. 1997. Identification of putative c-Myc-responsive genes: characterization of rcl , a novel growth-related gene. Mol. Cell. Biol. 17:4967–4978
   PubMedGoogle Scholar
• Littlewood, T. D., Amati, B., Land, H., and Evan, G. I.. 1992. Max and cMyc/Max DNA-binding activities in cell extracts. Oncogene 7:1783–1792
   PubMedGoogle Scholar
• Littlewood, T. D., Hancock, D. C., Danielian, P. S., Parker, M. G., and Evan, G. I.. 1995. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23:1686–1690
   PubMed Web of Science ®Google Scholar
• Lombardi, L., Newcomb, E. W., and Dalla-Favara, R.. 1987. Pathogenesis of Burkitt lymphoma: expression of an activated c- myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphocytes. Cell 49:161–170
   PubMed Web of Science ®Google Scholar
• Lund, T., Holtman, J., Frederiksen, M., and Laland, S. G.. 1983. On the presence of two new high mobility group-like proteins in HeLa S3 cells. FEBS Lett. 152:163–167
   PubMed Web of Science ®Google Scholar
• Lüscher, B., and Eisenman, R. N.. 1990. New light on myc and myb . 1. myc . Genes Dev. 4:2025–2035
   PubMed Web of Science ®Google Scholar
• Maher, J. F., and Nathans, D.. 1995. Multivalent DNA-binding properties of the HMG-I proteins. Proc. Natl. Acad. Sci. USA 93:6716–6720
   Google Scholar
• Masiakowski, P., Breathnath, R., Bloch, J., Gannon, F., Krust, A., and Chambon, P.. 1982. Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res. 10:7895–7903
   PubMed Web of Science ®Google Scholar
• Mateyak, M. K., Obaya, A. J., Adachi, S., and Sedivy, J. M.. 1997. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ. 8:1039–1048
   PubMedGoogle Scholar
• Miltenberger, R. J., Sukow, K. A., and Farnham, P. J.. 1995. An E box-mediated increase in cad transcription at the G1/S-phase boundary is suppressed by inhibitory c-Myc mutants. Mol. Cell. Biol. 15:2527–2535
   PubMed Web of Science ®Google Scholar
• Montgomery, R. A., and Dietz, H. C.. 1997. Inhibition of fibrillin 1 expression using U1 snRNA as a vehicle for the presentation of antisense targeting sequence. Hum. Mol. Genet. 6:519–525
   PubMed Web of Science ®Google Scholar
• Nathans, D., Christy, B. A., DuBois, R., Lanahan, A., Sanders, L. K., and Nakabeppu, Y.. 1991. Transcription factors induced by growth-signaling agents Origins of human cancer: a comprehensive review. Brugge, J. 353–364 Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y
   Google Scholar
• Nesbit, C. E., Tersak, J. M., and Prochownik, E. V.. 1999. MYC oncogenes and human neoplastic disease. Oncogene 18:3004–3076
   PubMed Web of Science ®Google Scholar
• Ogram, S. A., and Reeves, R.. 1995. Differential regulation of a multipromoter gene. J. Biol. Chem. 270:14235–14242
   PubMed Web of Science ®Google Scholar
• Packham, G., and Cleveland, J. L.. 1994. Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis. Mol. Cell. Biol. 14:5741–5747
   PubMed Web of Science ®Google Scholar
• Pena, A., Reddy, C. D., Wu, S., Hickok, N. J., Premkumar Reddy, E., Yumet, G., Soprano, D. R., and Soprano, K. J.. 1993. Regulation of human ornithine decarboxylase expression by the c-Myc-Max protein complex. J. Biol. Chem. 268:27277–27285
   PubMedGoogle Scholar
• Prendergast, G. C., and Ziff, E. B.. 1990. Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science 251:186–189
   Google Scholar
• Ram, T. J., Reeves, R., and Hosick, H. L.. 1993. Elevated high mobility group I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells. Cancer Res. 53:2655–2660
   PubMed Web of Science ®Google Scholar
• Rosenwald, I. B., Rhoads, D. B., Callanan, L. D., Isselbacher, K. J., and Schmidt, E. V.. 1993. Increased expression of eukaryotic translation initiation factors eIF-4E and eIF-2 alpha in response to growth induction by c-Myc. Proc. Natl. Acad. Sci. USA 90:6175–6178
   PubMed Web of Science ®Google Scholar
• Sambrook, J., Fritsch, E. F., and Maniatis, T.. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y
   Google Scholar
• Schuldiner, O., Eden, A., Ben-Yosef, T., Yanuka, O., Simchen, G., and Benvenisty, N.. 1989. 1996. ECA39 , a conserved gene regulated by c-Myc in mice, is involved in G1/S cell cycle regulation of yeast. Proc. Natl. Acad. Sci. USA 93:7143–7148
   Google Scholar
• Shen-Ong, G. L. C., Keath, E. J., Picolli, S. P., and Cole, M. D.. 1982. Novel myc oncogene RNA from abortive immunoglobin-gene recombination in mouse plasmacytomas. Cell 31:443–453
   PubMed Web of Science ®Google Scholar
• Shim, H., Dolde, C., Lewis, B. C., Wu, C.-S., Dang, G., Jungmann, R. A., Dalla-Favera, R., and Dang, C. V.. 1997. c-Myc transactivation of LDH-A : implications for tumor metabolism and growth. Proc. Natl. Acad. Sci. USA 94:6658–6663
   PubMed Web of Science ®Google Scholar
• Slamon, D. J., deKernion, J. B., Verma, I. M., and Cline, M. T.. 1984. Cellular oncogenes in human malignancies. Science 224:256–263
   PubMed Web of Science ®Google Scholar
• Small, M. B., Hay, N., Schwab, M., and Bishop, J. M.. 1987. Neoplastic transformation by the human gene N-myc. Mol. Cell. Biol. 7:1638–1645
   PubMed Web of Science ®Google Scholar
• Starborg, M., Gell, K., Brundell, E., and Hoog, C.. 1996. The murine Ki-67 cell proliferation antigen accumulates in the nucleolar and heterochromatic regions of interphase cells and at the periphery of the mitotic chromosomes in a process essential for cell cycle progression. J. Cell Sci. 109:143–153
   PubMed Web of Science ®Google Scholar
• Stone, J., deLange, T., Ramsey, G., Jakabovitz, E., Bishop, J. M., Varmus, H. E., and Lee, W.. 1987. Definition of regions in human c-Myc involved in transformation and nuclear localization. Mol. Cell. Biol. 7:1691–1709
   PubMedGoogle Scholar
• Strick, R., and Laemmli, U. K.. 1995. SARs are cis DNA elements of chromosome dynamics: synthesis of a SAR repressor protein. Cell 83:1137–1148
   PubMed Web of Science ®Google Scholar
• Sun, B., Hirsh, D. A., Jackson, D., and Beachy, P. A.. 1995. Ultrabithorax protein is necessary, but not sufficient for full activation of decapentaplegic expression of visceral mesoderm. EMBO J. 14:520–535
   PubMedGoogle Scholar
• Tamimi, Y., van der Poel, H. G., Denyn, M. M., Umbus, R., Karthaus, H. F., Dubruyne, F. M., and Shalken, J. A.. 1993. Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization. Cancer Res. 53:5512–5516
   PubMed Web of Science ®Google Scholar
• Tamimi, Y., van der Poel, H. G., Karthaus, H. F. M., Dubruyne, F. M. J., and Schalken, J. A.. 1996. A retrospective study of high mobility group I(Y) as progressive marker for prostate cancer determined by in situ hybridization. Br. J. Cancer 74:573–578
   PubMedGoogle Scholar
• Thanos, D., Du, W., and Maniatis, T.. 1993. The high mobility group protein HMG I(Y) is an essential structural component of viral-inducible enhancer complex. Cold Spring Harbor Symp. Quant. Biol. 58:73–81
   PubMedGoogle Scholar
• Thanos, D., and Maniatis, T.. 1995. Virus induction of human IFN-β gene expression requires the assembly of an enhanceosome. Cell 83:1091–1100
   PubMed Web of Science ®Google Scholar
• Thanos, D., and Maniatis, T.. 1992. The high mobility group protein HMGI(Y) is required for NF-kappaB-dependent virus induction of the human IFN-β gene. Cell 71:777–789
   PubMed Web of Science ®Google Scholar
• Van der Eb, A. J., and Graham, F. L.. 1980. Assay of transforming activity of tumor virus DNA. Methods Enzymol. 65:826–839
   PubMedGoogle Scholar
• Vartiane, E., Palvimo, J., Mahonen, A., Linnala-Kankkuren, A., and Maenpaa, P. H.. 1988. Selective decrease in low-M, HMG proteins HMGI and HMGY during differentiation of mouse teratocarcinoma cells. FEBS Lett. 228:45–48
   PubMedGoogle Scholar
• Vennstrom, B., Sheiness, D., Zabielski, J., and Bishop, J. M.. 1982. Isolation and characterization of c-myc, a cellular homolog of the oncogene (v-myc) of avian myelocytomatosis virus strain 29. J. Virol. 31:514–524
   Google Scholar
• Wang, J., Xie, L. Y., Allan, S., Beach, D., and Hannon, G. J.. 1998. Myc activates telomerase. Genes Dev. 12:1769–1774
   PubMed Web of Science ®Google Scholar
• Wechsler, D. S., and Dang, C. V.. 1992. Opposite orientations of DNA bending by c-Myc and Max. Proc. Natl. Acad. Sci. USA 89:7635–7339
   PubMedGoogle Scholar
• Williams, J. B., and Lanahan, A. A.. 1995. A mammalian delayed-early response gene encodes HNP36, a novel, conserved nucleolar protein. Biochem. Biophys. Res. Commun. 206:916–926
   PubMedGoogle Scholar
• Wu, K.-J., Polack, A., and Dalla-Favara, R.. 1999. Coordinated regulation of iron-controlling genes, H-Ferritin and IRP2 , by c-Myc. Science 283:676–679
   PubMed Web of Science ®Google Scholar
• Zhao, K., Kas, E., Gonzales, E., and Laemmli, U. K.. 1993. SAR-dependent mobilization of histone H1 by HMG-I/Y in vitro: HMG-I/Y is enriched in H1-depleted chromatin. EMBO J. 12:3237–3247
   PubMed Web of Science ®Google Scholar